Stock DCTH DELCATH SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Delcath Systems, Inc.

Equities

DCTH

US24661P8077

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
7.05 USD +4.29% Intraday chart for Delcath Systems, Inc. -9.38% +69.47%
May. 28 Delcath Systems, Inc. Appoints Bridget Martell to Board of Directors CI
May. 15 HC Wainwright Adjusts Price Target on Delcath Systems to $22 From $20, Maintains Buy Rating MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors
AQ
Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors
BU
Delcath Systems Reports First Quarter 2024 Results and Business Highlights
PR
Delcath Systems to Host First Quarter 2024 Earnings Call
PR
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
Delcath : Material Agreement - Form 8-K
PU
Delcath Announces Inducement Grant under Nasdaq Listing Rule 5635(4)
AQ
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PR
Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
PR
Delcath Systems Closes $7 Million Private Placement
PR
Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call
PR
Delcath Systems Appoints Martha S. Rook as Chief Operating Officer
PR
Delcath Systems Announces $7 Million Private Placement
PR
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
Delcath Systems to Participate in Upcoming Investor Conferences
PR
Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System)
PR
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO™ (melphalan/Hepatic Delivery System) Effective April 1, 2024
PR
Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
PR
Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT™
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DCTH Stock
  4. News Delcath Systems, Inc.
  5. Press Releases